4Maki N,Yoshiyama M,Omura T,et al.Effect of diltiazem on cardiac function assessed by echocardiography and neurohumoral factors after reperfused myocardial infarction without congestive heart failure[J].Cardiovasc Drugs Ther,2001,15(6):493-499.
5Edoute Y,Nagachandran P,Svirski B,et al.Cardiovascular adverse drug reaction associated with combined beta-adrenergic and calcium entry-blocking agents[J].J Cardiovasc Pharmacol,2000,35(4):556-559.
6Levine TB,Bernink PJ,Caspi A,et al.Effect of mibefradil,a T-type calcium channel blocker,on morbidity and mortality in moderate to severe congestive heart failure:the MACH-1 study[J].Mortality Assessment in Congestive Heart Failure Trial[J].Circulation.2000,101 (7):758-764.
7Mahgoub AA,El-Medany AH,Abdulatif AS,et al.A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure[J].Saudi Med J,2002,23(6):725-731.
二级参考文献1
1Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
